Trial of Labor After Cesarean
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 1,200
- 主要终点
- incidence of maternal request for trial of labor
研究概览
简要总结
in 2015 a protocol for trail of labor after a single cesarean delivery was approved by medical committee of Pescara Hospital. A database from outpatient clinic evaluated all women after 34 weeks' gestation with a previous cesarean delivery. Patients with a specific medical indication for cesarean delivery were skipped, whilst the others were recruited within repetitive elective cesarean delivery or trial of labor based on maternal request. Patients were couselled on the opportunity of having a mechanical induction/ rupture of membranes and subsequent oxytocin infusion if needed due to prolonged gestation (above 41 weeks plus 3 days) or medical indication to delivery (i.e. gestational diabetes, hypertension, SGA, etc.)
详细描述
All pregnant women with a previous CD attending Labor Ward of Santo Spirito Hospital of Pescara Italy (affiliated to University of Chieti Pescara) were enrolled at outpatient clinic after internal protocol registration for trial of labor in previus cesarean delivery. Patinets with a medical indication to CD were not elegible. Sociodemographic data such as ethnic background, maternal age, gestational age at delivery, previous vaginal birth, indications to previous CD, and maternal willingness to RECD ot TOLAC were recorded.
Maternal decision to switch to different intervention were recorded. Outcome of RECD and TOLAC were recorded.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 57 Years(Adult)
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •pregnant women
- •previous CD
排除标准
- •below 34 weeks' gestation
- •medical indication to CD
结局指标
主要结局
incidence of maternal request for trial of labor
时间窗: 11 years
incidence of women with request of trial of labor through the time
incidence of VBAC
时间窗: 11 years
number of vaginal birth through the time
次要结局
- maternal adverse outcome(11 years)
- neonatal adverse outcome(11 years)
研究者
Claudio Celentano
MD
G. d'Annunzio University
